Phibro Animal Health (PAHC) Work In Process (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Work In Process came in at $30.0 million in Q1 2026, up 9.68% year-on-year from $27.4 million in Q1 2025, and up 2.69% quarter-over-quarter from $29.2 million in Q4 2025.
Phibro Animal Health (PAHC) Work In Process (2013 - 2026) Analysis & Trends
Phibro Animal Health's Work In Process history runs 14 years deep, the most recent figure standing at $30.0 million for Q1 2026.
- On a quarterly basis, Work In Process rose 9.68% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was $30.0 million, a 9.68% increase from a year earlier, with the FY2025 full-year figure at $28.0 million, up 18.82% from the prior year.
- Work In Process rose to $30.0 million in Q1 2026 per PAHC's latest filing, from $29.2 million in the prior quarter.
- Across five years, Work In Process topped out at $30.0 million in Q1 2026 and bottomed at $12.9 million in Q1 2022.
- The 5-year median for Work In Process is $25.1 million (2023), against an average of $23.5 million.
- Across the five-year window, Work In Process surged 72.97% in 2022 and declined 0.47% in 2024, its largest moves.
- Year by year, Work In Process stood at $20.0 million in 2022, then gained by 25.27% to $25.1 million in 2023, then gained by 5.05% to $26.3 million in 2024, then gained by 11.0% to $29.2 million in 2025, then advanced by 2.69% to $30.0 million in 2026.
- Per Business Quant, the three latest PAHC Work In Process figures stand at $30.0 million (Q1 2026), $29.2 million (Q4 2025), and $25.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.01 Mn |
| Dec 31, 2025 | 29.23 Mn |
| Sep 30, 2025 | 25.79 Mn |
| Jun 30, 2025 | 27.98 Mn |
| Mar 31, 2025 | 27.36 Mn |
| Dec 31, 2024 | 26.33 Mn |
| Sep 30, 2024 | 25.04 Mn |
| Jun 30, 2024 | 23.55 Mn |
| Mar 31, 2024 | 26.11 Mn |
| Dec 31, 2023 | 25.07 Mn |
| Sep 30, 2023 | 25.16 Mn |
| Jun 30, 2023 | 22.35 Mn |
| Mar 31, 2023 | 20.11 Mn |
| Dec 31, 2022 | 20.01 Mn |
| Sep 30, 2022 | 17.39 Mn |
| Jun 30, 2022 | 15.47 Mn |
| Mar 31, 2022 | 12.90 Mn |
| Dec 31, 2021 | 11.89 Mn |
| Sep 30, 2021 | 10.05 Mn |
| Jun 30, 2021 | 12.74 Mn |